Stonepine Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,909,207
| Closed | -$2.76M | – | 33 |
|
|
2019
Q4 | $2.76M | Buy |
3,909,207
+205,787
| +6% | +$145K | 1.92% | 15 |
|
|
2019
Q3 | $2.69M | Buy |
3,703,420
+3,212,324
| +654% | +$2.33M | 2.61% | 15 |
|
|
2019
Q2 | $383K | Buy |
+491,096
| New | +$383K | 0.26% | 24 |
|
|
2019
Q1 | – | Sell |
-531,662
| Closed | -$447K | – | 36 |
|
|
2018
Q4 | $447K | Sell |
531,662
-1,197,225
| -69% | -$1.01M | 0.39% | 21 |
|
|
2018
Q3 | $5.12M | Sell |
1,728,887
-64,024
| -4% | -$190K | 2.99% | 12 |
|
|
2018
Q2 | $6.6M | Sell |
1,792,911
-67,089
| -4% | -$247K | 4.01% | 10 |
|
|
2018
Q1 | $6.51M | Buy |
1,860,000
+165,283
| +10% | +$578K | 3.49% | 10 |
|
|
2017
Q4 | $5.29M | Sell |
1,694,717
-131,647
| -7% | -$411K | 3.17% | 12 |
|
|
2017
Q3 | $12.8M | Sell |
1,826,364
-26,031
| -1% | -$183K | 7.57% | 5 |
|
|
2017
Q2 | $17.1M | Buy |
1,852,395
+291,908
| +19% | +$2.69M | 9.23% | 3 |
|
|
2017
Q1 | $16.8M | Buy |
1,560,487
+36,453
| +2% | +$392K | 9.44% | 3 |
|
|
2016
Q4 | $12.8M | Buy |
+1,524,034
| New | +$12.8M | 7.64% | 6 |
|